A multicentre, randomised, double-blind, parallel group study on the therapeutic efficacy and safety of Febuxostat (taken once daily) and the therapeutic efficacy and safety of Allopurinol on serum urate concentration in subjects suffering from hyperuricemia and gout.
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Febuxostat (Primary) ; Allopurinol
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Menarini
- 02 Dec 2016 This trial has been completed in Greece (end date: 2016-10-24), according to European Clinical Trials Database record.
- 19 Feb 2013 New trial record